Epileptogenesis After Stroke: Current Insights Into Molecular and Structural Mechanisms

Area of Science:

• Neuroscience
• Neurology
• Epileptology

Background:

• Stroke is a leading cause of acquired epilepsy in adults, causing significant long-term disability.
• Epileptogenesis post-stroke is a multi-phase process involving structural damage and molecular alterations.
• Current treatments primarily focus on seizure suppression rather than prevention.

Purpose of the Study:

• To explore the mechanisms of epileptogenesis after stroke.
• To identify potential biomarkers for risk stratification and therapeutic trials.
• To review promising therapeutic strategies beyond seizure suppression.

Main Methods:

• Review of recent advances in neuroimaging, electrophysiology, and molecular profiling.
• Analysis of candidate biomarkers including imaging signatures and molecular markers.
• Evaluation of preclinical and translational studies on anti-epileptogenic therapies.

Main Results:

• Candidate biomarkers (lesion characteristics, imaging, EEG, proteins, microRNAs) show promise but require validation.
• Multimodal, longitudinal biomarker strategies could aid risk stratification and serve as surrogate endpoints.
• Therapeutic approaches targeting inflammation, oxidative stress, and metabolism show preclinical promise.

Conclusions:

• Understanding the interplay of structural damage and molecular signaling is crucial for stroke-induced epilepsy prevention.
• Biomarker frameworks are essential for developing effective anti-epileptogenic strategies.
• Future research should focus on validating biomarkers and translating promising therapies to reduce the burden of post-stroke epilepsy.